Overall, these results suggest that (i) Yap/Taz are dispensable for cell transformation and dissemination in MLL-AF9-driven leukemia and that (ii) Yap/Taz are not tumor suppressive in either N-RASG12D or MLL-AF9-driven AMLs. This evidence concerns the gene KMT2A and leukemia.